Cargando…
Structural insights into targeting of the colchicine binding site by ELR510444 and parbendazole to achieve rational drug design
Microtubules consisting of α- and β-tubulin heterodimers have proven to be an efficient drug target for cancer therapy. A broad range of agents, including ELR510444 and parbendazole, can bind to tubulin and interfere with microtubule assembly. ELR510444 and parbendazole are colchicine binding site i...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033620/ https://www.ncbi.nlm.nih.gov/pubmed/35478655 http://dx.doi.org/10.1039/d1ra01173a |